Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceBusiness Wire • Tuesday
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)Business Wire • 08/06/24
Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial ResultsBusiness Wire • 07/18/24
Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung CancerBusiness Wire • 06/03/24
Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)Business Wire • 06/02/24
Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual MeetingBusiness Wire • 05/23/24
Earnings Preview: Puma Biotech (PBYI) Q1 Earnings Expected to DeclineZacks Investment Research • 04/25/24
Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial ResultsBusiness Wire • 04/18/24
Puma Biotechnology (PBYI) Soars 14.0%: Is Further Upside Left in the Stock?Zacks Investment Research • 03/22/24
Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast CancerBusiness Wire • 03/20/24